- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Total 3245 results
-
Hospital Universitario Dr. Jose E. GonzalezNovartis PharmaceuticalsCompletedLeukemia, Myeloid, Chronic, BCR-ABL PositiveMexico
-
Novartis PharmaceuticalsCompletedLeukemia, Myeloid, ChronicIsrael
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Acute Erythroid Leukemia | Acute Megakaryoblastic Leukemia | Myelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | Blast Phase Chronic Myelogenous Leukemia,... and other conditionsUnited States
-
CepheidCompletedLeukemia, Myelogenous, ChronicUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Terminated
-
UConn HealthCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedLeukemiaUnited States
-
Novartis PharmaceuticalsCompletedChronic Myelogenous Leukemia in Chronic PhaseUnited States
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAcute Lymphoblastic Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive | Recurrent Acute Lymphoblastic Leukemia | t(9;22) | BCR-ABL1 Fusion Protein ExpressionUnited States
-
University of LiverpoolImperial College London; Newcastle University; University of GlasgowUnknownChronic Myeloid LeukaemiaUnited Kingdom
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsTerminatedMyelogenous Leukemia, Chronic, Chronic PhaseUnited States
-
Cancer Trials IrelandCompletedLeukemiaUnited States, Ireland, Israel, Germany
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)Terminated
-
Kanto CML Study GroupUnknownLeukemia, Myelogenous, Chronic, BCR-ABL Positive | Myelogenous Leukemia, Chronic, Chronic PhaseJapan
-
M.D. Anderson Cancer CenterActive, not recruitingAcute Lymphoblastic Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Untreated Adult Acute Lymphoblastic Leukemia | Accelerated Phase Chronic Myelogenous Leukemia,... and other conditionsUnited States
-
University of California, San FranciscoAmerican Society of HematologyCompletedChronic Myeloid Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Myeloproliferative NeoplasmUnited States
-
xunaRecruiting
-
Novartis PharmaceuticalsNo longer availableChronic Myelogenous Leukemia (CML)
-
University Hospital, BordeauxCompleted
-
Shenzhen TargetRx, Inc.M.D. Anderson Cancer CenterRecruitingChronic Myelogenous LeukemiaUnited States
-
Samara State Medical UniversityRecruitingChronic Myeloid LeukaemiaRussian Federation
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedChronic Myeloid LeukaemiaItaly
-
Australasian Leukaemia and Lymphoma GroupMerck Sharp & Dohme LLC; Novartis PharmaceuticalsUnknownChronic Myeloid LeukaemiaAustralia
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)Terminated
-
Bristol-Myers SquibbCompletedChronic Myelogenous LeukemiaNetherlands, United States, Italy, Argentina, Brazil, Canada, Germany, Peru, Singapore, Taiwan, United Kingdom, France, Korea, Republic of, Philippines, Sweden, Thailand, Finland, Australia, Israel, Belgium, Denmark, Norway, Switzer...
-
M.D. Anderson Cancer CenterRecruitingChronic Myelogenous LeukemiaUnited States
-
Shenzhen TargetRx, Inc.Peking University People's HospitalRecruitingChronic Myelogenous LeukemiaChina
-
Novartis PharmaceuticalsActive, not recruitingChronic Myelogenous LeukemiaUnited States, United Kingdom, Hungary, Japan, Saudi Arabia, Australia, Germany, Canada, France, Netherlands, Spain, Lebanon, Turkey, Korea, Republic of, Argentina, Brazil, Bulgaria, Czechia, Israel, Italy, Mexico, Romania, Russian... and more
-
Ariad PharmaceuticalsCompletedChronic Myelogenous Leukemia | Hematologic MalignanciesUnited States
-
Bristol-Myers SquibbCompletedChronic Myelogenous LeukemiaJapan
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Cord Blood Transplant RecipientUnited States
-
Bio-Path Holdings, Inc.WithdrawnAcute Myeloid Leukemia | Myelodysplastic Syndrome | Chronic Myelogenous Leukemia, Ph1-PositiveUnited States
-
Novartis PharmaceuticalsCompletedPhiladelphia Chromosome Positive | Chronic Myelogenous Leukemia in Chronic PhaseJapan
-
American University of Beirut Medical CenterRecruitingChronic Myelogenous LeukemiaLebanon
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Beth Israel Deaconess Medical CenterCompleted
-
III. Medizinische Klinik MannheimUnknownLeukemiaSwitzerland, Germany, Spain, Poland, Czech Republic
-
Siriraj HospitalRecruiting
-
Baylor Research InstituteCompletedMyelodysplastic Syndromes | Acute Myelogenous Leukemia | Chronic Myelogenous LeukemiaUnited States
-
NovartisCompletedLeukemiaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
Novartis PharmaceuticalsActive, not recruitingChronic Myelogenous LeukemiaSpain, United Kingdom, Germany, Canada, Austria, France, Korea, Republic of, Greece, Singapore, Italy, Argentina, Poland, Vietnam, Malaysia, Oman, Brazil
-
University Hospital, AngersCompletedSolid Tumor | Endothelial Dysfunction | Tumor Angiogenesis | CML (Chronic Myelogenous Leukemia)France
-
University of Maryland, BaltimoreUniversity of Maryland Greenebaum Cancer CenterCompleted
-
Masonic Cancer Center, University of MinnesotaTerminated
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)Completed